University of Maryland Cancer Center Secures $3 Million Federal Grant to Advance Oncology Health Equity Research

UMGCCC receives a $3M NCI grant to fund the ARCH K12 Program, training the next generation of oncology researchers to tackle cancer disparities in the community.

By: AXL Media

Published: Mar 28, 2026, 5:07 AM EDT

Source: Information for this report was sourced from University of Maryland School of Medicine

A Strategic Investment in Diverse Oncology Leadership

The National Cancer Institute has selected the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center as a primary site for developing a new generation of medical researchers. Through the $3 million Career Development Award, the center will establish the Advancing Oncologic Research Communities in Health Equity program, specifically designed to bridge the gap between laboratory breakthroughs and community application. This funding ensures that emerging scientists have the financial and institutional backing to focus on cancers that disproportionately affect underserved populations, creating a sustainable pipeline of specialized oncology talent.

Exclusive National Recognition for Baltimore Research

In a notable distinction for the University of Maryland School of Medicine, the cancer center was the only institution in the United States to receive this specific grant from the NCI during the 2025-2026 cycle. According to Taofeek K. Owonikoko, the Executive Director of the center, the award serves as a formal validation of the university's existing model for community-informed treatment. By focusing on the unique demographic needs of the Maryland region, the program aims to set a national standard for how urban cancer centers can integrate local population data into global oncology practices.

The Collaborative Framework of the ARCH K12 Program

The management of the grant will be overseen by a multidisciplinary team of principal investigators, including experts in pharmacology, epidemiology, and clinical oncology. This collaborative structure is intended to provide scholars with a holistic view of the disease, moving beyond traditional silos to understand how biology, environment, and social factors intersect. Stuart Martin, the center’s deputy director, noted that the momentum of cancer research over the last thirty years can only be sustained if early-stage researchers are given the resources to pursue high-risk, high-reward community oncology projects.